Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
Author(s) -
Elin Aamdal,
Eva Skovlund,
Kari Dolven Jacobsen,
Oddbjørn Straume,
Christian Kersten,
Oluf Herlofsen,
Jarle Karlsen,
Israr Hussain,
Anita Amundsen,
Astrid Dalhaug,
Marta Nyakas,
Kirsten T. Hagene,
Kjersti Holmsen,
Steinar Aamdal,
S. Kaasa,
Tormod Kyrre Guren,
Jon Amund Kyte
Publication year - 2022
Publication title -
esmo open
Language(s) - English
Resource type - Journals
ISSN - 2059-7029
DOI - 10.1016/j.esmoop.2022.100588
Subject(s) - medicine , ipilimumab , quality of life (healthcare) , melanoma , clinical trial , hazard ratio , cancer , oncology , confidence interval , immunotherapy , nursing , cancer research
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom